Bindu Ann George Palapura

Bindu Ann George Palapura is a partner at Potter Anderson & Corroon LLP, where her patent litigation practice spans a diverse range of technology and life sciences sectors. She focuses on patent, trademark, and trade secret litigation for clients ranging from startups to Fortune 50 companies. Her experience encompasses pharmaceuticals, chemicals, software, medical devices, and semiconductors. Palapura demonstrates versatility in her practice, representing both plaintiffs and defendants. While her tracked case appearances show a slight inclination towards defendant-side work (2 defendant, 1 plaintiff), her broader experience includes successfully defending operating companies against significant claims and securing substantial plaintiff-side jury verdicts.

Palapura is based at Potter Anderson & Corroon, a prominent Delaware law firm recognized for its intellectual property practice and frequent appearances in the U.S. District Court for the District of Delaware. The firm frequently serves as local counsel in complex patent infringement cases due to its deep understanding of Delaware's legal landscape. Her notable engagements include successfully defending Apple Inc. against a $30 million patent infringement claim related to LTE technology and assisting AngioDynamics in defending a $67.5 million patent infringement suit. She also secured an $82.5 million jury trial victory for IBM in an infringement case against Groupon Inc. More recently, Palapura helped secure a $20.2 million jury verdict for Harbour Antibodies BV in a patent infringement case involving antibody technology, where willful infringement was found against Amgen Inc. and Teneobio Inc.

Her recent case involvement further illustrates her broad technical and strategic capabilities. In Guardant Health, Inc. v. Tempus AI, Inc., she acted as local counsel for the plaintiff in a dispute over liquid biopsy sequencing methods and cancer diagnostics, a case that was subsequently transferred to the Northern District of California. As local counsel for Apple Inc. in MYW Semitech, LLC v. Apple Inc., she defended against allegations of infringing high-density multichip packaging patents, where a motion for a stay pending inter partes review (IPR) was denied. In Neurocrine Biosciences, Inc. v. Spruce Biosciences Inc, Palapura served as counsel for the defendant in a pharmaceutical patent infringement action concerning treatments for congenital adrenal hyperplasia, which was dismissed without prejudice for lack of subject matter jurisdiction after facing related post-grant review (PGR) proceedings where Neurocrine sought to invalidate Spruce's patents. This experience demonstrates her familiarity with PTAB proceedings and their interaction with district court litigation.

Bindu Ann George Palapura is admitted to the Delaware Bar. Prior to her legal career, she was an associate in GlaxoSmithKline's IT Development Program, managing technology and process-improvement projects within pharmaceutical R&D.